Letter: immunogenicity is not the root cause for loss of response to anti‐ <scp>TNF</scp> agents in patients with <scp>IBD</scp> in <scp>TDM</scp> era-Reference-Cited by-同舟云学术

Letter: immunogenicity is not the root cause for loss of response to anti‐ TNF agents in patients with IBD in TDM era

Published:2022-03-22 Issue:7 Volume:55 Page:885-886
ISSN:0269-2813
Container-title:Alimentary Pharmacology & Therapeutics
language:en
Short-container-title:Aliment Pharmacol Ther

Author:

Alsoud Dahham¹^ORCID,Verstockt Bram¹²^ORCID,Vermeire Séverine¹²

Affiliation:

1. KU Leuven, Department of Chronic Diseases, Metabolism and Ageing Translational Research in Gastrointestinal disorders (TARGID) – IBD Unit Leuven Belgium

2. Department of Gastroenterology and Hepatology KU Leuven, University Hospitals Leuven Leuven Belgium

Publisher

Wiley

Subject

Pharmacology (medical),Gastroenterology,Hepatology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/apt.16797

Reference9 articles.

1. Loss of response to anti‐TNFα agents depends on treatment duration in patients with inflammatory bowel disease

2. HLA-DQA1*05 Carriage Associated With Development of Anti-Drug Antibodies to Infliximab and Adalimumab in Patients With Crohn’s Disease

3. Immunogenicity to infliximab is associated with HLA-DRB1

4. A Genetic Variation in the Neonatal Fc-Receptor Affects Anti-TNF Drug Concentrations in Inflammatory Bowel Disease

5. Antibodies‐to‐infliximab accelerate clearance while dose intensification reverses immunogenicity and recaptures clinical response in paediatric Crohn’s disease

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. HLA-DQA1*05 Allele Carriage and Anti-TNF Therapy Persistence in Inflammatory Bowel Disease;Inflammatory Bowel Diseases;2024-06-27

2. Ultrasound transmural healing correlates with higher adalimumab drug concentration in Crohn's disease only in the short-term.;Revista Española de Enfermedades Digestivas;2024

3. Safety and Monitoring of Inflammatory Bowel Disease Advanced Therapies;Inflammatory Bowel Diseases;2023-07-14

4. Recent Advances in the Optimization of Anti-TNF Treatment in Patients with Inflammatory Bowel Disease;Journal of Clinical Medicine;2023-03-23